StockData
Onconetix, Inc. logo

Onconetix, Inc. (ONCO) stock

ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$3.21+0.18 (+5.94%)

Close on Nov 13, 2026Market cap $12.68MP/E –Yield –

Onconetix profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Onconetix's profit margin for the twelve months ending Sep 30, 2026 was -7423.9%. For fiscal 2025 it was -1721.0%, against -2325.2% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-1721.0%+604.2
FY2024Dec 31, 2024-2325.2%+61661.3
FY2023Dec 31, 2023-63986.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-30741.4%−27848.7
Q2 FY2026Jun 30, 2026-16748.3%−14520.5
Q1 FY2026Mar 31, 2026-19643.4%−11234.5
Q4 FY2025Dec 31, 20251867.5%+6002.2
Q3 FY2025Sep 30, 2025-2892.7%−1952.0
Q2 FY2025Jun 30, 2025-2227.8%−198.0
Q1 FY2025Mar 31, 2025-8408.8%−6821.4
Q4 FY2024Dec 31, 2024-4134.7%–
Q3 FY2024Sep 30, 2024-940.7%–
Q2 FY2024Jun 30, 2024-2029.8%–
Q1 FY2024Mar 31, 2024-1587.4%–

More Onconetix figures

See a number that looks wrong?